Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martí-Vilalta, J.-L.
Right arrow Articles by Kase, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martí-Vilalta, J.-L.
Right arrow Articles by Kase, C. S.

(Stroke. 1999;30:183-184.)
© 1999 American Heart Association, Inc.


In Memoriam

Julio Hernán García, MD

December 22, 1933–November 8, 1998

José-Luis Martí-Vilalta, MD1


1 Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Carlos S. Kase, MD2


2 Department of Neurology, Boston University, Boston, Massachusetts

With the untimely death of Julio H. García, MD, the neurological and stroke community in the United States and abroad has lost an esteemed colleague and a respected researcher. Julio died on November 8, 1998, as a result of subarachnoid hemorrhage from a ruptured cerebral aneurysm.

Julio H. García was born in Armenia, Colombia, and completed his medical education and initial training in pathology in Bogotá. He then emigrated to the United States at age 26 to further his instruction in pathology, eventually becoming a neuropathologist. His mentor in neuropathology was Stanley M. Aronson, with whom Julio always maintained close ties. His career subsequently took him to the Medical College of Virginia in 1964, the University of Tennessee in 1967, and Baylor College of Medicine in 1970, during which time he was developing a growing interest in the neuropathology of cerebrovascular diseases. In 1971, he became Head of the Division of Neuropathology at the University of Maryland. In this capacity, and over the following 8 years, he produced a number of important publications in the area of the neuropathology of stroke. He became interested in the development of experimental stroke models, always directed by the idea of using these models for the testing of clinically relevant problems. Following a year's stay in Bonn, Germany, as a recipient of the Alexander von Humboldt Senior US Scientist Award, he continued his studies of human and experimental neuropathology of stroke at the University of Alabama in Birmingham, where he became the Director of . . . [Full Text of this Article]